Toldot Genetics uses whole genome sequencing to develop and apply algorithm-based tools and approaches for assigning genetic variations to clinical conditions. The company provides geneticists and physicians with a complete analysis package of exome sequencing data for identifying the causal mutations of rare genetic disorders. Pharmaceutical and biotechnology companies use Toldots services in their clinical pipelines, from design to deep analysis of their sequencing data. Toldots solutions are exclusively tailored for the requirements of each project, incorporating gold-standard tools with in-house algorithms and software. Toldot Genetics is a subsidiary of BATM Advanced Communications.